|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Electrochemical and in-situ X-ray diffraction studies of the reaction of lithium with tin oxide composite显示文摘 | Courtney I A Dhan J R | 1997 | J Electrochem Soc1997，144，： | 1 |
| 2 | Standoff distance and bow shock phenomena in the cold spray process 显示文摘 | PATTISON J CELOTTO S DHAN A | 2008 | Surface and Coatings Technology2008，202，8： | 1 |
| 3 | Key factors controlling the reversi-bility of the reaction of lithium with SnO2 and SnBPO6显示文摘 | Courtney I A Dhan J R | 1997 | J Electrochem Soc1997，144，： | 1 |
| 4 | Key factors controlling the reversibility of the reaction of lithium with SnO2 and Sn2 BPO6 glass显示文摘 | COURTNEY I A DHAN J R | 1997 | J Electrochem Soc1997，144，： | 1 |
| 5 | Analysis of infected blood cell imams using morphological operators显示文摘 | RUBERTO C D DEMPSTR A DHAN S | 2002 | ELSEVIER Image and Vision Computing2002，20，2： | 1 |
| 6 | Density of states in graphite from electrochemical measurements on Lix BzC1-z)6显示文摘 | Dhan J R Reimers J N Sleigh A K | 1992 | Phys Rev B1992，45，7： | 1 |
| 7 | Key factors controlling the reversibility of the reaction of lithium with SnO2 and SnBPO6显示文摘 | Courtney I A Dhan J R | 1997 | J Electrochem Soc1997，144，： | 1 |
| 8 | Electrochemical and in-situ X-ray diffraction studies of the reaction of lithium with the oxide composite显示文摘 | Courtney I A Dhan J R | 1997 | J Electrochem Soc1997，144，： | 1 |
| 9 | Innova- tive cermic-fiber technology energizes advanced cera- metrics 显示文摘 | CASS R B DHAN A MOHAMMADI F | 2003 | American Ceramic Society Bulletin2003，82，11： | 1 |
| 10 | New-onset diabetes in COVID-19 and clinical outcomes: A systematic review and meta-analysis显示文摘BACKGROUND Diabetes mellitus(DM)is associated with adverse clinical outcomes and high mortality in patients with coronavirus disease 2019(COVID-19).The relationship between diabetes and COVID-19 is known to be bidirectional.AIM To analyze the rate of new-onset diabetes in COVID-19 patients and compare the clinical outcomes of new-onset diabetes,pre-existing diabetes,hyperglycemic,and non-diabetes among COVID-19 patients.METHODS We used the Meta-analysis of Observational Studies in Epidemiology statement for the present meta-analysis.Online databases were searched for all peerreviewed articles published until November 6,2020.Articles were screened using Covidence and data extracted.Further analysis was done using comprehensive meta-analysis.Among the 128 studies detected after thorough database searching,seven were included in the quantitative analysis.The proportion was reported with 95%confidence interval(CI)and heterogeneity was assessed using I2.RESULTS Analysis showed that 19.70%(CI:10.93-32.91)of COVID-19 patients had associated DM,and 25.23%(CI:19.07-32.58)had associated hyperglycemia.The overall mortality rate was 15.36%(CI:12.57-18.68)of all COVID-19 cases,irrespective of their DM status.The mortality rate was 9.26%among non-diabetic patients,10.59%among patients with COVID-19 associated hyperglycemia,16.03%among known DM patients,and 24.96%among COVID-19 associated DM patients.The overall occurrence of adverse events was 20.52%(CI:14.21-28.70)among COVID-19 patients in the included studies,15.29%among non-diabetic patients,20.41%among patients with COVID-19 associated hyperglycemia,20.69%among known DM patients,and 45.85%among new-onset DM.Metaregression showed an increasing rate of mortality among new hyperglycemic patients,known diabetics,and new-onset DM patients in comparison to those without diabetes.CONCLUSION A significantly higher rate of new onset DM and hyperglycemia was observed.Higher mortality rates and adverse events were seen in patients with new-onset DM and hyperglycemia than in the non-diabetic population. | Dhan Bahadur Shrestha Pravash Budhathoki Sumit Raut Sugat Adhikari Prinska Ghimire Sabin Thapaliya Ali A Rabaan Bibodh Jung Karki | 2021 | World Journal of Virology2021，10，5： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员